Please login to the form below
disease awareness
This page shows the latest disease awareness news and features for those working in and with pharma, biotech and healthcare.
Rare Disease Day 2023 – raising awareness around the world
Raising awareness for people living with a rare disease remains a very important task,” the pair said. ... Also raising awareness for this year’s Rare Disease Day, Havas Health &You has partnered with with H4B Boston and Beyond the Diagnosis to
Latest news
-
New healthcare comms agency, POP Health, launches in London
The services on offer span across all areas of healthcare communications; from disease awareness, patient advocacy, product/corporate, internal communications, and issues management.
-
NHS England launches lung cancer awareness drive in country’s cancer hotspots
end. Minister for Health, Will Quince, said: “Lung cancer kills nearly 27, 000 people each year in England and we must do more to fight this disease. ... Raising awareness of the main symptoms is crucial, and this new NHS and Roy Castle Lung Cancer
-
Cannes Lions shows health creative is becoming an art form
The net result is writ large in the shortlists and winner profiles; a glut of entries in public health categories but fewer campaigns for pharmaceutical products; a flood of disease awareness ... transit). In it, the agency hired a van to drive around
-
Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
The partnership aims to increase awareness of the chronic metabolic liver disease among patients, healthcare providers and other stakeholders. ... raise awareness of the disease and highlight the importance of early diagnosis and management.
-
Your new goal for communications – social impact
There has never been a greater awareness of these issues, nor have they been so prominent on agendas the world over. ... Our work reflects that. From disease awareness campaigns to patient engagement programmes, we seek to reduce harm and improve the
More from news
Approximately 50 fully matching, plus 209 partially matching documents found.
Latest Intelligence
-
Improving cardiovascular disease care and awareness
PME: How did the COVID-19 pandemic impact care for patients with cardiovascular disease? ... Atherosclerotic disease can affect those in their 30s, so there needs to be much more awareness of this, to enable people to take the right steps to protect
-
Critical success factors and the increasing value of rare disease clinical trials
Also, best-in-class companies embrace innovation, overcome access and availability challenges, frame tight inclusion/exclusion criteria and promote disease awareness. ... When pharma companies work with the advocacy groups, they can grow the disease
-
The increasing value of rare disease trials
Increasing awareness around lack of treatment options to address these needs has led to a growing number of clinical trials. ... The limited public awareness of the disease or clinical trial can make it difficult to reach potential participants.
-
Cannes Lions shows health creative is becoming an art form
The net result is writ large in the shortlists and winner profiles; a glut of entries in public health categories but fewer campaigns for pharmaceutical products; a flood of disease awareness ... transit). In it, the agency hired a van to drive around
-
How Resonant’s innovation and creativity resolve healthcare communications challenges
The Anthem team understands the importance of uniting corporate perspectives with disease awareness, brand and molecule-specific understanding.
More from intelligence
Approximately 1 fully matching, plus 68 partially matching documents found.
Latest appointments
-
Evoke KYNE promotes Carolyn Coyle to executive vice president
Coyle has over 15 years of experience in the healthcare communications industry, with expertise in strategic brand and franchise communications, disease awareness programming, data and regulatory milestones and advocacy and influencer
-
Makara Health bolsters team with six new hires
Harris joins from Havas Lynx, where she worked for three years across a number of branded, disease awareness and internal comms campaigns. ... disease awareness activities.
-
New faces at Lucid Group and ZPB Associates
Working across global and UK centric campaigns, Petra covered product communications, corporate communications, disease awareness and media liaison.
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications
He joins the company from OPEN Health Group, where he spent the last two years in PR and Communications, supporting market access-focused communications and disease awareness projects.
-
Tonic Life Communications strengthens leadership team
Ungar has more than 15 years’ experience in healthcare public relations and her expertise lies in delivering strategic campaigns surrounding market shaping/disease awareness, FDA approvals, secondary indications, as well as ... Stephanie DeViteri,
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
Live video has a number of practical applications with both patient and professional audiences, for example as part of Patient Support Programming (PSPs) where patient experts get to share their disease ... part of disease awareness campaigning.
-
emotive supports Rare Disease Day 2019
With a series of events and activities over the week leading up to Rare Disease Day on February 28th, we showed our support for stimulating greater awareness of Rare Diseases along ... And finally on the 28th, Rare Disease Day, our London office was
-
Anthem PR
We understand the importance of uniting corporate perspectives with disease awareness, brand, and molecule-specific understanding.
-
You’re sitting on a time bomb, so think harder and give more!
It will impact all of us whether we’re institutional managers, carers, healthcare professionals and practitioners, commissioners, manufacturers of medicine or devices or, like us, purveyors of medical education and disease ... Better medical education,
-
ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY
We understand the importance of uniting corporate perspectives with disease awareness, brand, and molecule-specific understanding.
More from PMHub
Approximately 15 fully matching, plus 104 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Italy accelerates the path towards digital therapeutics implementation
- AstraZeneca’s mild combination asthma reliever approved in UK
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- The speed of science and the pace of comms
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
